0114-9954
Reactions Weekly
Adis, Springer Healthcare · New Zealand
- APC
- —
- Time to publish
- —
- Articles/yr
- 298,762
Open access
DOAJ
No APC
Active
Exploration of Digestive Diseases
ISSN-L 2833-6321
Open Exploration Publishing Inc. · China · 2022
Submission → publication16 weeks
APCNo APC
DOAJ✓
Earliest year2022
Value profile v0.1
Topics
Liver Disease Diagnosis and Treatment14%
Liver Disease and Transplantation6%
Drug-Induced Hepatotoxicity and Protection5%
Inflammatory Bowel Disease4%
Hepatitis B Virus Studies4%
Liver Diseases and Immunity4%
Hepatocellular Carcinoma Treatment and Prognosis4%
Helicobacter pylori-related gastroenterology studies3%
Academic impact
- Cited at least once
- 61%
- Top 10% share of citations
- 40%
- Median citations
- 3
Influential citation share
- Influential citation share
- 3%
Semantic Scholar · 93 DOI
Originality (citation structure)
- References shared with peer papers
- 8%
- Self-journal citations
- 0%
Structural proxies from reference lists of sampled papers; not a verdict on originality.
Integrity
Retracted: 0
Most cited works
- Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases 2024 · 30 cites
- The central role of mitochondrial metabolism in hepatic steatosis 2024 · 18 cites
- Impact of mitochondrial lipid alterations on liver disease mechanisms and progression 2024 · 16 cites
- The multiple mechanisms and modes of cell death after acetaminophen overdose 2025 · 15 cites
- Helicobacter pylori infection and metabolic syndrome 2024 · 15 cites
Most recent works
- The interplay of insulin resistance, glycemic variability, and metabolic dysfunction-associated steatotic liver disease 2026 · 3 cites
- Helicobacter pylori and gastric MALT lymphoma: mechanisms of pathogenesis and therapeutic implications 2026 · 1 cites
- Therapeutic role of JAK inhibitors in hepatogastrointestinal diseases 2026 · 1 cites
- LncRNAs in hepatocellular carcinoma: molecular drivers and emerging therapeutic targets 2026 · 1 cites
- From microbes to molecules: mechanistic insights into metabolite-mediated gut inflammation 2026 · 1 cites
Based on 96 works from OpenAlex (CC0) · method v0.1
Basic information
- Publisher
- Open Exploration Publishing Inc.
- Country/Region
- China
- Subject
- Medicine
- Open access
- ✓ (gold)
- DOAJ
- ✓
- License
- CC BY
- Earliest year
- 2022
- DOAJ article records
- 138
- Journal website
- https://www.explorationpub.com/Journals/edd
- Verify this journal
-
ISSN Portal ↗ ·
Master Journal List ↗
· DOAJ ↗
✓ ISSN checksum valid - Submission page
- https://www.explorationpub.com/Journals/edd/Aut…
Reference data How to read journal metrics →
Articles/yr143
h-index10
2-yr mean citedness2.36
Last publication year2026
DOAJ article records138
Open access✓
“2-yr mean citedness” is the OpenAlex field summary_stats.2yr_mean_citedness (CC0): mean citations per paper over a two-year window. It is a raw bibliometric field, not a journal rating, and is not used for default ranking.
Correct a record · Request removal
Subject classification
Medicine42
Biochemistry, Genetics and Molecular Biology14
Pharmacology, Toxicology and Pharmaceutics13
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology1
§
More →
Journals in the same subject
0006-4971
Blood
Elsevier BV · United States
- APC
- $5,500
- Time to publish
- —
- Articles/yr
- 183,281
0732-183X
Journal of Clinical Oncology
Lippincott Williams & Wilkins · United States
- APC
- —
- Time to publish
- —
- Articles/yr
- 170,452
0016-5085
Gastroenterology
Elsevier BV · United States
- APC
- $4,180
- Time to publish
- —
- Articles/yr
- 154,907
0022-5347
The Journal of Urology
Lippincott Williams & Wilkins · United States
- APC
- $3,000
- Time to publish
- —
- Articles/yr
- 147,097
0892-6638
The FASEB Journal
Wiley · United States
- APC
- $3,740
- Time to publish
- —
- Articles/yr
- 139,152